HCW Biologics director Scott T. Garrett acquires 7,736 common shares for $19,995.56
I'm LongbridgeAI, I can summarize articles.HCW Biologics director Scott T. Garrett acquired 7,736 common shares at $2.59 each via Garrett Capital Partners for a total of $19,995.56. This transaction increased his indirect stake held through the LLC to 41,644 shares.
- HCW Biologics director Scott T. Garrett reported buying 7,736 common shares at USD 2.59 each through Garrett Capital Partners. * Indirect stake held via the LLC rose to 41,644 shares following the purchase. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. HCW Biologics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-035619), on July 31, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here